焦树德治疗结核性胸膜炎经验应用效果分析.docVIP

作者简介：陈杰勇（1978-），男，河北衡水人，主治医师，学士，研究方向：肺结核、结核性胸膜炎、麻疹等呼吸道传染疾病,电子支气管镜应用。Tel0318-2394418，E-mail:chenjieyong66@。 焦树德治结核性胸膜炎效果分析 (衡水市第三人民医院　 　00) 摘要: 目的:治结核性胸膜炎方法64 例中至大量游离结核性胸腔积液患者随机分为治疗组和对照组。治疗组常规胸穿抽液。统计治疗组进行效果分析。结果59 例患者参与最后结果分析。治疗组、对照组胸膜肥厚发生 率是 67 %、310 %(有效率分别是:933 %、690 %) ( P 0.05) ；治疗组胸腔积液消失时间短,具有极显著性差异。结论应用,有效防止胸膜肥厚粘连的发生。 关键词’s Tuberculosis Pleurisy Therapy CHEN Jie-Yong (The 3rd People’s Hospital of Hengshui City,Hengshui 053000, Hebei, China) Abstract: Objective: To explore the clinic effect of Jiao Shude’s tuberculosis pleurisy therapy in decreasing the vanishing time of hydrothorax and preventing pleura thickening and adhesion. Methods: Sixty-four patients with free tuberculosis pleural effusion, defined as middle to large pleural effusions, were randomized into two groups. Patients in treat group were given Chinese herbs treatment besides pasid and routine thoracentesis. Then analyze the statistics data of 2 groups’ treatment effect from the therapy started to three months after. Results: 59 patient s were available for final analysis. The incidence rate of residual pleural thickening at 3rd month were 6.7 % in treatment group and 31.0 % in control group (the effective rates are 93.3 % vs.69.0 % separately) ( P 0.05) ；the vanishing time of pleural effussion in treat group is significant shorter than control group. Conclusion: to apply Jiao Shude’s therapy in tuberculosis pleurisy, which combines traditional Chinese and western medicine, can significantly decrease the vanishing time of pleural effussion, and effectively prevent pleura thickening. Key Word: Tuberculosis Pleurisy; Pleural Effusion；Residual Pleural Thickening; therapy of combining traditional Chinese and Western medicine 目前,结核病仍是全球发病率及死亡率最高的可防治的感染性疾病。结核性胸膜炎是肺外结核中仅次于淋巴结结核第二常见的形式[1]。结核性胸膜炎是54.8 %[2]。胸膜肥厚是常见的后遗症严重者可致胸膜纤维化目前 ,临床上常用胸腔内给药来防治胸膜肥厚作者,现报道如下。 1 　资料与方法 11 　一般资料 　2008年月—200年月期间科住院患者 64 例 ,符合结核性胸膜炎诊断标准[]，且肺内均无病变，无糖尿病、癫痫、矽肺及严重肝、肾功能损害等并存症，WBC在正常范围。X线提示中至大量游离性胸腔积液5.0cm ,未包裹 ,无胸膜肥厚或胸膜